Purpose: Dosimetry for melanoma-targeted radionuclide therapy (TRT) with [
INTRODUCTION
Targeted radionuclide therapy (TRT) is an interesting strategy associating radiation to a molecular target. In particular, radioimmunotherapy has demonstrated high efficiency due to an increase in dose delivered to tumor cells when radiolabeled antibodies bind tumor-associated antigen. 1 Besides antibodies and analogs, smaller molecules (organic ligands, peptides, etc.) can also be used to address TRT to cells overexpressing an antigen or a cognate receptor. [2] [3] [4] [5] For example, 177 Lu-DOTA-octreotate peptides, somatostatin receptor ligands, are clinically relevant for neuroendocrine tumor treatments. 6 Other specificities can be achieved with small molecules like melanin ligands belonging to the arylcarboxamide family, first developed for melanoma imaging. [7] [8] [9] Targeting melanin is of interest for the treatment of disseminated melanoma as it is present in restricted tissues in humans 10 and is observed in 25-50% of metastatic lesions.
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The challenge for melanoma treatment lies in the capacity to eradicate heterogeneous lesions, particularly when cells become resistant to antiproliferative drugs. 15 TRT of pigmented melanoma using beta emitters can be of interest, as the low range of electrons (few millimeters) is adapted to damage nonpigmented neighboring cancer cells in a metastatic lesion. To this aim, several radiotracers, targeting specific characteristics of pigmented melanoma, have been evaluated. For example, antibodies against melanin or melanoma chondroitin sulfate proteoglycan (MCSP), a-MSH peptides, that are ligands of melanocyte receptors (MC1R) or melanin-targeting ligands from arylcarboxamide family, have been radiolabeled with several radionuclides and successfully assessed in preclinical and clinical studies. [16] [17] [18] [19] The feasibility of transferring such a strategy to humans was recently achieved by Mier et al. 20 using [ 131 I]BA52 in patients screened for melanin-positive metastases. This TRT allowed unusual long survivals (more than 2 yr) for three out of five patients having received an activity higher than 4.3 GBq. 20 Beyond the perspectives of phase I trials, dosimetry may guide therapy before treatment. 21 Even if absorbed dose-effect relationship is poorly documented, it would appear that personalized treatments, based on accurate dosimetric studies, would improve outcome and survival. 22 This is clearly the case for TRT strategies applied to pigmented and metastasized melanoma. Besides a significant decrease in tumor growth in preclinical models, the level of melanin in lesions is directly correlated with the uptake of melanin-targeting radiotracers, as shown for [
123 I] ICF01012 and [
123 I]BZA2 in preclinical and multicentric clinical imaging studies. 9, 23 We already investigated effectiveness of [ 131 I]ICF01012 for therapeutic targeting of melanin-positive melanoma in mice through in vivo experiments 24 coupled with dose calculations 25 to organs of interest using the GATE Monte Carlo platform. [26] [27] [28] It was shown that, in C57BL6 mouse model highly pigmented eyes, the uptake of [ 131 I]ICF01012 was significant, with an absorbed dose to eyes of 117.2 Gy while 96 Gy were delivered to the tumor for an injected activity of 37 MBq. Therefore, a dosimetry study in nonrodent species (healthy pigmented rabbits), following the same methodology planned for short-term phase I clinical trial, is presented in this paper. Two kinds of melanin resulting from polymerization of chemical blocks are present in vertebrates, 10 the ratio of these two polymers is responsible for phenotype pigmentation of eyes, skin, and hair. The proportion of melanin then varies upon species and between individuals from a same species. For example, in C57Bl6 mice, we find mainly eumelanin. 29 For rabbits used in this study, we focus on the melanin content in eyes. As described in Durairaj et al., 30 the melanin content differs significantly from human and rabbits (the melanin content in rabbits being up to four times higher than for humans). Therefore, we pay attention to quantify the melanin content in human and rabbit's eyes using the same methodology. Absorbed doses to nontarget organs are assessed using the MIRD formalism 31 based on the distributions of [
131 I]ICF01012 measured from two different approaches: SPECT imaging under clinical conditions and tissue sampling (ex vivo measurements). We calculated S values, that is, the absorbed dose to a target organ per unit cumulated activity in a source organ, using the GATE Monte Carlo platform on rabbit CT scans. Even if no ocular toxicity was observed during the clinical study of [ 131 I]BA52 (a melanintargeting analog of ICF01012), 20 we performed a detailed study for this organ. An extrapolation to human organs is also proposed, except for eyes, using the OLINDA/EXM 32 software with the RADAR formalism. 33 
MATERIALS AND METHODS

2.A. [ 131 I]ICF01012 radiolabeling
The nonradiolabeled ICF01012, 34 is prepared as described by Chezal et al. 8 while the tributylstannyl precursor N-(2-diethylaminoethyl)-6-(tributylstannyl)quinoxaline-2-carboxamide is obtained following a published procedure. 35 
2.C. SPECT-CT imaging
Experiments are performed on a dual-head SPECT/CT device (Symbia â Siemens) with a high-energy parallel-hole collimator.
2.C.1. Calibration study
The calibration factor, that converts counts to activity, is calculated using a 10-cm-radius cylindrical phantom, volume of 5640 mL, filled with pure water injected with 85.34 MBq of iodine-131. This phantom approximates the attenuation and diffusion conditions in rabbit imaging. Acquisition and reconstruction parameters are described in Section 2.C.3. The phantom activity is measured with a dose calibrator (Lemer Pax â ) calibrated according to current standard. The calibration factor is 0.6035 MBq/ kcps.
2.C.2. Partial volume correction (PVC)
Since a large volume is used to determine the calibration factor, a PVC is applied to small volume according to the MIRD recommendations (pamphlet 24). 37 PVC study is performed using a NEMA NU2 image quality phantom containing six spheres of 26.5, 11.5, 5.6, 2.6, 1.2, and 0.5 mL. All spheres are filled with a solution of 2.15 MBq/mL; the activity in the largest sphere is 57.15 MBq at the beginning of the acquisitions. Recovery coefficients (RC) are defined in Eq. (1) as the ratio of the activity measured using the CTscan based VOI (A CT ), to the activity measured on SPECTbased VOI (A SPECT ) taking into account the spill out effect.
The RC values of 0.74, 0.63, 0.53, 0.40, 0.26, and 0.09 for sphere diameters of 3.7, 2.8, 2.2, 1.7, 1.3, and 1.0 cm, respectively, have been calculated. In Fig. 1 , RC values are plotted as a function of sphere diameters and fitted according to an exponential curve obtained in Eq. (2) .
The 1-cm-diameter sphere has been excluded from the data as the volume segmentation was too challenging. Medical Physics, 45 (11), November 2018 expectation maximization (3D OSEM) algorithm, including attenuation correction. CT scans (130 kV, 30 mAs), 512 9 512 image size with 0.98 9 0.98 9 2.0 mm voxel size, are produced after reconstruction.
The RC values extracted from the exponential fit curve in Eq. (2) are shown in Table I . As stated in the review of Erlandsson et al., 38 when calculating RC values for object of different sizes and shapes scanned on an imaging system, RC values are strongly dependent on object size, the shape has no influence. So, the volume of each organ has been measured from CT imaging; corresponding sphere volumes and sphere diameters have been then deduced.
We can notice that the RC value obtained for eyes (0.37), is close to the value (0.32) mentioned in Rault et al. 39 It was not possible to compare RC values for other organs with the literature, as sphere diameters are usually found to be less than 20 mm.
2.C.4. Time-activity data
Organs (liver, spleen, kidneys, lungs, brain, stomach, and heart) are segmented on CT scans, using the ISOgray Treatment Planning System (TPS) software (DosiSoft â , Cachan, France). The segmentation obtained for each organ has been used on SPECT images to get time-activity data. Then, timeintegrated activities per organ are obtained using a Matlab (program version R2012a, the MathWorks Inc., Natick, Massachusetts, USA) trapz function extrapolating data, when necessary, till complete disintegration. Organs of interest are dissected and weighed. Activity is measured using a c-counter (Wizard 1480, Perkin Elmer, Waltham, MA, USA). The percentage of injected activity (% IA/ g), corrected for the radioactive decay, is calculated. For liver, they are removed and processed following the same procedure as described in Section 2.F.1 for rabbit's eyes. A part of the liver is counted to establish a standard curve. Time-integrated activities per organ are then obtained using a Matlab (program version R2012a, the MathWorks Inc.) trapz function extrapolating data, when necessary, till complete disintegration. Table II presents mean organ masses and associated standard deviations for sampling and imaging methods.
2.D.2. [ 131 I]ICF01012 half-life and stability in blood
Blood is collected via the marginal ear vein at different times postinjection from 5 to 1400 min. To collect [
131 I] ICF01012 from blood, an extraction with methanol/0.1 N aqueous sodium hydroxide solution is performed; then, supernatants are analyzed with High Performance Liquid Chromatography (HPLC) as previously described in Ref. [40] . The yield of extracted radioactivity is 94 AE 10%.
2.E. Absorbed doses for rabbits and extrapolation to humans
2.E.1. Absorbed doses for rabbits
Absorbed dose to organs are calculated through GATE Monte Carlo simulations based on the MIRD methodology 41 using time-integrated activity data (obtained from tissue sampling and imaging) and CT scans for three rabbits. For each rabbit (n = 3), S values are calculated using GATE version 8.0 and "emstandard_opt3" physics list, designed for any . For each organ, a simulation is performed to compute S value using a uniform distribution of iodine-131. Thus, the whole beta spectrum (from 10 to 766 keV) and the relevant discrete emissions (internal conversion electrons and Auger electrons) characteristic of iodine-131 are considered in all simulations according to ICRP 30 nuclear data. 43 A sufficient number of particles is generated in order to reach statistical uncertainty less than 1%.
2.E.2. Extrapolation to humans
Absorbed doses to human organs are estimated using the OLINDA/EXM software 32 using time-integrated activities, calculated from SPECT-CT imaging, and extrapolated from animals to humans using the %-kg/g method. Forty-micrometer-thick slices are obtained using a Reichert-Jung Cryopolycut (Leica instrument, Rueil-Malmaison, France) then, cryo-slices are dehydrated during 48 h, at À22°C. The entire process is performed as described in Ref. [45] . Activity quantification is performed using a quantitative autoradiography digital analyzer (b-imager, Biospace Lab, Paris, France). A calibration curve is used to convert measurements (cpm/mm 2 ) to activity (kBq/g). Control rabbits are injected with low activity of [ 131 I]ICF01012 and euthanized.
2.F.2. Melanin quantification
Human eyes (n = 10) from five patients (two men, three women), with different colors, are obtained from the Clermont Auvergne University's department of legal medicine (France) and stored in PBS (phosphate-buffered saline) at 4°C until dissection. Nontreated rabbit eyes are removed after euthanasia and stored at 4°C in PBS. For human and rabbit eyes, the dissection protocol is the same: the cornea is first removed to isolate the lens, the ciliary body and the iris; in a second time, the aqueous humor is pulled off and the retina, retinal pigmented epithelium (RPE), and choroid are recovered by scratching the sclera. As it is difficult to isolate each pigmented compartment, ciliary bodies and the iris are pooled together, the same for retina, RPE, and choroid. These samples are weighed and stored at À80°C. They are further thawed, crushed, and dissolved in a 1 M aqueous potassium hydroxide solution and incubated at 60°C during 30 min, until complete lysis. The absorbance is measured at 405 nm and melanin concentration is determined using a standard curve performed with synthetic melanin (Sigma-Aldrich, St Quentin-Fallavier, France). Melanin content is expressed as lg per mg of tissue.
2.F.3. Dosimetry study
We calculate specific S values for eye tissues using the GATE Monte Carlo platform. For that, a human eye is modeled following sizes, conformations and thicknesses of tissues found in histological sections. Eye was modeled with a water sphere of 12.5 mm in radius (corresponding mass is 8.2 g). Retina (corresponding mass is 0.85 g), RPE, and choroid are modeled using concentric shells (described with polar angles 0 h 360 and 0 u 150 Þ of respective thicknesses 500 lm, 20 lm, and 200 lm (see Fig. 2 ). Iris and ciliary bodies are modeled using a concentric shell (described with polar angles: 0 h 360 and 30 u 180 Þ. The absorbed dose is scored in eye, retina, V 1 = iris +ciliary bodies (corresponding mass is 1.2 g), and V 2 = RPE + choroid + retina (corresponding mass is 73 mg) tissues.
From Table V in V 1 and V 2 is equivalent to the mass proportions of these tissues; therefore, we considered placing the iodine radioactive source in a 20 lm concentric shell (corresponding to RPE thickness) circling the eye at the border of the retina. Thus, the absorbed dose to volumes V, D V ðGyÞ; was calculated as:
with:Ã eye the time-integrated activity to human eye (Bq s g À1 ) and S (V Source) the absorbed dose per disintegration in a volume V in (Gy Bq À1 s À1 ).
2.G. Statistical analysis
All data are represented as a mean for at least three values. Statistical significance was calculated by a two-tailed Student's test for unpaired samples. Mean differences were considered to be significant when P < 0.05.
RESULTS
3.A. Comparison between SPECT-CT imaging and sampling biodistributions
Planar dynamic acquisitions are shown in Fig. 3 . After injection, [
131 I]ICF01012 reached the heart compartment and then is accumulated rapidly in the liver. In blood, the % of IA is low, reaching 0.02% per mL in the first minutes, and decreasing very slowly to 0.01% of IA at 24 h (see Fig. 4 Fig. 7) . Table II presents organ masses and time-integrated activities in Bq s g À1 for 1 MBq injected for eyes, liver, spleen, kidneys, lung, brain, heart, and stomach. Although some differences can be observed between measured (sampling) and calculated (CT imaging) organ masses (i.e., spleen, heart, and stomach), time-integrated activities are significantly different for spleen. For eyes, we can notice that time-integrated activity is under evaluated through SPECT-CT imaging; therefore, it is decided to use the sampling value for the evaluation of the dose in the following section.
3.B. Absorbed dose calculation and extrapolation to humans
Mean S values are given in Table III and absorbed doses to organs with extrapolated time-integrated activities to human are provided in Table IV . For rabbits, absorbed doses are ranked from 1.14 AE 0.50 Gy/GBq for heart to 6.38 AE 0.51 Gy/GBq for liver. For eyes, highly pigmented in Fauve de Bourgogne species, absorbed dose calculated with time-integrated activity from sampling 45.8 AE 7.9 Gy/GBq is chosen for the extrapolation to humans. Extrapolated Then, we assess the melanin content in rabbit and human eyes (see Table V ). Melanin concentration is 3.6 times lower in human RPE (6.10 AE 1.71 lg/mg) than in the Fauve de Bourgogne one (21.84 AE 10.41 lg/mg). Interestingly, activity was mainly located in the RPE and ciliary bodies (see Fig. 8 ), this feature cannot be assessed considering SPECT-CT low-resolution reconstruction. Activities in RPE and choroid are difficult to distinguish on images. Higher activity is located at the boundary with the optic nerve and strong punctuated activities are also seen at the anterior pole of the eye where ciliary bodies/iris are located. Quantitative autoradiography of rabbit uvea (see Fig. 8) shows a maximum at 6 h postinjection of [ 131 I]ICF01012 that is in agreement with data from sampling (see Fig. 6 ).
When we calculate specific S values for human eye tissues using the GATE Monte Carlo platform (see Table VI ), the resulting absorbed dose to eye, using an extrapolated timeintegrated activity of 1.93 AE 0.44 E+11 Bq s/GBq, is 0.53 AE 0.12 Gy/GBq. Doses to retina, V 1 and V 2 are 3.07 AE 0.70, 3.32 AE 0.76, and 4.19 AE 0.96 Gy/GBq, respectively.
DISCUSSION AND CONCLUSION
The TRT can be considered as a recent approach in clinics compared to external beam radiation. As such, new improvements of TRT aim to reduce side effects by evaluating an accurate activity to deliver through imaging. In this study, we compare time-integrated activities obtained from sampling and SPECT imaging in order to validate SPECT-CT information to be used in a forthcoming clinical transfer. We show that time-integrated activities are comparable for all studied organs with quantification performed either using SPECT or sampling, except for spleen. Otherwise, organ mass values are in the same range except for heart, spleen, and stomach leading to a statistical difference in cumulated activities only for spleen. Discrepancy between premortem and postmortem volume of some organs are widely described in literature. Heart volumes decrease from about 50% 46 between premortem and postmortem states. Additionally, some organs like spleen are highly sensitive to the utilization of anesthesia drugs. 47 The heart beatings, breathing, and blood flow can also affect scan reconstruction and crossorgan absorbed doses. 48 We only consider uniform distribution of the radiotracer in all organs, except for eyes, due to melanin-specific targeting. Such an assumption should not modify dose calculations compared to interindividual variations. In case of metastases observed in humans, we would perform voxelized dose calculations 49 to personalize the dosimetry.
Two studies reported dosimetry calculations for similar iodine-131-labeled benzamides, one in cynomolgus monkeys 50 and the other in humans. 20 Our extrapolated values to human are in similar range to those obtained for cynomolgus monkey SPECT imaging. Concerning eyes, when comparing dose calculated using GATE simulations, our value is lower with 0.53 AE 0.12 Gy/GBq vs 1.3 AE 0.67 for cynomolgus study. These two results keep lower than those found in the 20 Here, we confirm that radioactivity is highly present in RPE as shown in Fig. 8 . We further investigated by calculating S values to human eye tissues with the GATE Monte Carlo platform using standard dimensions and shapes found in the literature. Thanks to a precise determination of melanin in human eyes, we conclude that activity is homogeneous in a volume equivalent to RPE thickness all around the eye. The dose to retina is then evaluated to be 3.07 AE 0.70 Gy/GBq, similar to the value found in clinical study (2.7 Gy/GBq) using [
131 I]BA52 20 where imaging is acquired in planar mode without partial volume correction.
In conclusion, we show that integrated time activities from sampling and imaging experiments are comparable in nonrodent species, for pigmented Fauve de Bourgogne rabbits. The calculation of S factors using SPECT-CT imaging allows us to reach absorbed doses to organs for this model. The extrapolation of doses to human ends to similar values published for another melanin ligand. 20, 30 Concerning eye toxicity, we use biodistribution data and imaging data corrected with partial volume and physical parameters of human eyes taking into account the difference in melanin content between rabbits and humans. This methodology provides accurate information on dose to eye that has never been assessed yet in other studies. Tools developed in this study will be used in phase I clinical transfer of [ 131 I]ICF01012. 
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